Gain Therapeutics, Inc. (GANX) Operating Lease, Right-of-Use Asset USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Gain Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2020 to 2024.
  • Gain Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $384 K, a 37% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $384 K -$226 K -37% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $459 K -$201 K -30.4% Dec 31, 2023 10-Q 2024-05-14
Q3 2023 $491 K -$180 K -26.8% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $560 K -$186 K -25% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $610 K -$221 K -26.6% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $660 K -$241 K -26.8% Dec 31, 2022 10-K 2024-03-26
Q3 2022 $670 K -$77.3 K -10.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $746 K -$66.5 K -8.19% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $831 K +$332 K +66.6% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $901 K +$378 K +72.3% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $748 K Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $812 K Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $499 K Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $523 K Dec 31, 2020 10-K 2022-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.